HRT Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$131K Sell
2025
Q1
$169K Buy
2023
Q4
Sell
2023
Q3
$1.12M Buy
2023
Q2
$328K Buy
2022
Q4
Sell
2022
Q3
$876K Buy
2022
Q2
Sell
2022
Q1
$1.18M Buy
2021
Q4
Sell
2021
Q3
$1.05M Buy
2020
Q4
Sell
2020
Q3
$2.37M Buy
2019
Q2
Sell
2019
Q1
$176K Buy